Eagle's Eye View: Your Weekly CV Update From ACC.org

Latest Episodes:

Eagle’s Eye View: Your Weekly CV Update from ACC.org (Week of Dec. 19) Dec 20, 2022

Show notes

In 2022 with much of the care landscape returning to more normalcy after the COVID-19 pandemic eased, we saw the most visited journal scan content on ACC.org once again focused on common areas of cardiovascular practice and areas with advances in therapy. ACC.org is a home for condensed, digestible content particularly around important summary documents like the guidelines and consensus statements. In 2022, we saw release of new heart failure guidelines, new guidelines for the evaluation of cardiovascular disorders prior to non-cardiac surgery and also for pulmonary hypertension, a summary statement on the use of aspirin for primary prevention, and a state-of-the-art summary on rhythm control for atrial fibrillation.

The ACC looks forward to an exciting 2023 and the opportunity to continue to partner with you in the provision of “state of the art” information for your practice!

— Kim A. Eagle, MD, MACC

Subscribe to Eagle’s Eye View

ACCEL Lite: Top Takeaways from 2022: Electrophysiology with DJ Lakkireddy Dec 15, 2022

Show notes

In this interview, Dhanunjaya "DJ" Lakkireddy MBBS, FACC and Alison L. Bailey MD FACC discuss the Top Takeaways from 2022: Electrophysiology.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

Eagle’s Eye View: Your Weekly CV Update from ACC.org (Week of Dec. 12) Dec 14, 2022

Show notes

In this week’s View, Dr. Eagle discusses a systematic review and meta-analysis of aortic stenosis progression, then looks at a meta-analysis of randomized trials on the use of dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk. Finally, Dr. Eagle explores the three-year results of the SUCCOUR trial that investigated cardioprotection using strain-guided management of potentially cardiotoxic cancer therapy'

Subscribe to Eagle’s Eye View

Eagle’s Eye View: Your Weekly CV Update from ACC.org (Week of Dec. 5) Dec 07, 2022

Show notes

In this week’s View, Dr. Eagle discusses medical masks versus N95 respirators for preventing COVID-19 among health care workers, then looks at an excellent metanalysis of antioxidant micronutrient supplementation to reduce cardiovascular risk. Finally, Dr. Eagle explores the prognosis of myocarditis developing after mRNA COVID-19 vaccination compared to viral myocarditis.

Subscribe to Eagle’s Eye View

Eagle’s Eye View: Your Weekly CV Update from ACC.org (Week of Nov. 21) Nov 23, 2022

Show notes

In this week’s View, Dr. Eagle discusses trends in the use of oral anticoagulants in older adults with newly diagnosed atrial fibrillation, then looks at a collaborative meta-analysis of large placebo-controlled trials that examines the impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes. Finally, Dr. Eagle explores insights from the PEGASUS-TIMI 54 trial regarding patient selection for long-term secondary prevention with ticagrelor.

Subscribe to Eagle’s Eye View

Eagle’s Eye View: Your Weekly CV Update from ACC.org (Week of Nov. 14) Nov 16, 2022

Show notes

In this week’s View, Dr. Eagle discuses hypertension management in patients with cardiovascular comorbidities, then looks at a patient-level analysis of Phase III trials that examines Inclisiran and cardiovascular events. Finally, Dr. Eagle explores the STROKESTOP study on the cost-effectiveness of population screening for atrial fibrillation.

Subscribe to Eagle’s Eye View

Eagle’s Eye View: Your Weekly CV Update from ACC.org (Week of Nov. 7) Nov 09, 2022

Show notes

In this week’s View, Dr. Eagle discusses the most important aspects of the new ACC AHA Guidelines for the diagnosis and management of aortic disease.

Subscribe to Eagle’s Eye View

Day 3 Highlights | AHA 2022 Nov 07, 2022

Show notes

Drs. Deepak Bhatt, Kim Eagle and Payal Kohli review Day 3 late-breaking science from AHA 2022, including ENHANCE-AF (0:32), PRECSION (2:40), BrightHTN (4:08), and SPYRAL HTN-ON (6:41). The ACC is providing coverage of the hottest AHA 2022 science. For trial summaries, news coverage, daily video wrap-ups and more, visit ACC's Meeting Coverage page and follow the ACC on social media using the hashtag #AHA22 to join the conversation.

Day 2 Highlights | AHA 2022 Nov 07, 2022

Show notes

Drs. Deepak Bhatt, Kim Eagle and Payal Kohli review Day 2 late-breaking science from AHA 2022, including ECMO-CS (0:42), RESPECT-EPA (2:22), ISCHEMIA-EXTENDed (5:45) and EMPA-KIDNEY (7:39). The ACC is providing coverage of the hottest AHA 2022 science. For trial summaries, news coverage, daily video wrap-ups and more, visit ACC's Meeting Coverage page and follow the ACC on social media using the hashtag #AHA22 to join the conversation.

Eagle's Eye View: Day 1 Highlights | AHA 2022 Nov 05, 2022

Show notes

In this special AHA episode of Eagle’s Eye View, Drs. Deepak Bhatt, Kim Eagle and Payal Kohli discuss highlights from Day 1 of the AHA 2022 late-breaking science, including TRANSFORM-HF, DCP, PROMINENT, and IRONMAN. The ACC is providing coverage of the hottest AHA 2022 science. For trial summaries, news coverage, daily video wrap-ups and more, visit ACC's Meeting Coverage page and follow the ACC on social media using the hashtag #AHA22 to join the conversation.

Our TOPPODCAST Picks

Follow Us

Stay Connected

Eagle’s Eye View: Your Weekly CV Update From ACC.org

Related Podcasts

Links

Stay Connected